| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | SB52334 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |